| News & Announcements | Coverage of the COVID-19 Vaccination for AmeriHealth Members (Updated May 2, 2022) | | | | | | 5/2/2022 | | | |
| News & Announcements | Preventive Coverage of FDA-Approved Contraceptive Mobile Applications for Amerihealth Members | | | | | | 5/31/2022 | | | |
| New Policies | GIVOSIRAN (GIVLAARI®) | 08.00.21 | 4/1/2022 1:00 PM | 5/2/2022 | | | 5/2/2022 | This is a New Policy. | | |
| New Policies | Allogeneic Processed Thymus Tissue-agdc (Rethymic®) | 08.01.88 | 4/13/2022 3:00 PM | 5/16/2022 | | | 5/16/2022 | This is a New Policy. | | |
| New Policies | Psychiatric Collaborative Care Management (CoCM) (AmeriHealth) | 00.01.70 | 4/29/2022 11:00 AM | 5/30/2022 | | | 5/30/2022 | This is a New Policy. | | |
| Updated Policies | Botulinum Toxin Agents | 08.00.26y | | 5/9/2022 | | | 5/9/2022 | Medical Necessity Criteria;Medical Coding | | |
| Updated Policies | Ustekinumab (Stelara®) | 08.00.82m | | 5/9/2022 | | | 5/9/2022 | Medical Necessity Criteria;Medical Coding | | |
| Updated Policies | Denosumab (Prolia®, Xgeva®), Romosozumab-aqqg (Evenity®) | 08.00.94p | | 5/9/2022 | | | 5/9/2022 | Medical Necessity Criteria | | |
| Updated Policies | Manual Wheelchairs | 05.00.12i | | 5/23/2022 | | | 5/23/2022 | General Description, Guidelines, or Informational Update | | |
| Updated Policies | Isatuximab-irfc (Sarclisa®) | 08.00.46c | | 5/23/2022 | | | 5/23/2022 | Medical Necessity Criteria | | |
| Updated Policies | Hematopoietic Stem Cell Transplantation (Bone Marrow Transplant) | 11.07.01v | | 5/23/2022 | | | 5/23/2022 | General Description, Guidelines, or Informational Update | | |
| Reissue Policies | Smell and Taste Dysfunction Testing | 07.11.01c | | 5/7/2018 | 5/4/2022 | | 5/4/2022 | | | |
| Reissue Policies | Pain Management of Peripheral Nerves by Injection | 07.03.27 | | 12/27/2021 | 5/4/2022 | | 5/4/2022 | | | |
| Reissue Policies | Enzyme Replacement Therapy for Mucopolysaccharidosis (e.g., Aldurazyme®, Elaprase®, Vimizim®, Naglazyme®, Mepsevii™, etc.) | 08.00.70e | | 6/3/2019 | 5/4/2022 | | 5/4/2022 | | | |
| Reissue Policies | Reimbursement for Components of Comprehensive Laboratory Panels | 00.01.61a | | 6/15/2020 | 5/4/2022 | | 5/4/2022 | | | |
| Reissue Policies | Interleukin-5 (IL-5) Antagonist (e.g., Cinqair®) | 08.01.23i | | 10/4/2021 | 5/4/2022 | | 5/5/2022 | | | |
| Reissue Policies | Laboratory-Based Vestibular Function Testing | 07.03.24b | | 1/1/2021 | 5/4/2022 | | 5/5/2022 | | | |
| Reissue Policies | Electromyography (EMG) (Needle and Non-Needle) of the Anal or Urethral Sphincter | 07.03.21l | | 10/1/2019 | 5/4/2022 | | 5/5/2022 | | | |
| Reissue Policies | Treatment of Pulmonary Artery Hypertension with Intravenous, Subcutaneous, and Inhaled Pharmacologic Agents | 08.00.25m | | 11/22/2021 | 5/4/2022 | | 5/6/2022 | | | |
| Reissue Policies | Mohs' Micrographic Surgery | 11.08.23j | | 10/1/2018 | 5/4/2022 | | 5/9/2022 | | | |
| Reissue Policies | Application and Removal of Tattoos | 11.08.05g | | 7/20/2012 | 5/4/2022 | | 5/9/2022 | | | |
| Reissue Policies | Octreotide Acetate (Sandostatin® LAR Depot) | 08.01.10g | | 10/25/2021 | 5/4/2022 | | 5/9/2022 | | | |
| Reissue Policies | Inebilizumab-cdon (Uplizna) | 08.01.68b | | 8/9/2021 | 5/4/2022 | | 5/9/2022 | | | |
| Reissue Policies | Burosumab-twza (Crysvita®) | 08.01.49b | | 3/15/2021 | 5/4/2022 | | 5/9/2022 | | | |
| Reissue Policies | Alglucosidase alfa (e.g., Lumizyme®), Avalglucosidase alfa-ngpt (Nexviazyme® ) | 08.00.72k | | 4/1/2022 | 5/4/2022 | | 5/9/2022 | | | |
| Reissue Policies | Cerliponase alfa (Brineura®) | 08.01.39c | | 6/3/2019 | 5/4/2022 | | 5/9/2022 | | | |
| Reissue Policies | Enzyme Replacement for the Treatment of Gaucher's Disease | 08.00.51k | | 6/7/2021 | 5/4/2022 | | 5/9/2022 | | | |
| Reissue Policies | Repair of Cleft Lip, Cleft Nose, and/or Cleft Palate | 11.03.01f | | 12/21/2020 | 5/18/2022 | | 5/18/2022 | | | |
| Reissue Policies | Surgical Correction of Strabismus | 11.05.07d | | 9/7/2016 | 5/18/2022 | | 5/18/2022 | | | |
| Reissue Policies | Belantamab mafodotin-blmf (Blenrep) | 08.01.70b | | 4/1/2021 | 5/18/2022 | | 5/18/2022 | | | |
| Reissue Policies | Gastric Electrical Stimulation (Enterra™), Gastric Pacing | 11.03.15i | | 11/30/2020 | 5/18/2022 | | 5/18/2022 | | | |
| Reissue Policies | Refractive Keratoplasty | 11.05.01f | | 7/1/2019 | 5/18/2022 | | 5/18/2022 | | | |
| Reissue Policies | Implantation of Intrastromal Corneal Ring Segments (ICRS) | 11.05.11c | | 9/7/2016 | 5/18/2022 | | 5/18/2022 | | | |
| Reissue Policies | Removal of Breast Implants | 11.08.14m | | 10/1/2021 | 5/18/2022 | | 5/18/2022 | | | |
| Reissue Policies | Contact Lenses for the Treatment of Persistent (Corneal) Epithelial Defects | 07.13.11k | | 10/1/2021 | 5/18/2022 | | 5/18/2022 | | | |
| Reissue Policies | Islet Cell Transplantation | 11.04.01d | | 1/1/2020 | 5/18/2022 | | 5/18/2022 | | | |
| Reissue Policies | Labiaplasty | 11.06.09d | | 5/14/2018 | 5/18/2022 | | 5/18/2022 | | | |
| Reissue Policies | Lysis of Epidural Adhesions | 11.15.13d | | 2/14/2016 | 5/18/2022 | | 5/18/2022 | | | |
| Reissue Policies | Partial Coherence Interferometry | 07.13.08e | | 4/23/2018 | 5/18/2022 | | 5/18/2022 | | | |
| Reissue Policies | Mentoplasty or Genioplasty | 11.14.01g | | 6/25/2017 | 5/18/2022 | | 5/18/2022 | | | |
| Reissue Policies | Surgical Treatments of Athletic Pubalgia | 11.14.26a | | 6/3/2015 | 5/18/2022 | | 5/18/2022 | | | |
| Reissue Policies | Extracorporeal Shock Wave Therapy (ESWT) for Musculoskeletal Conditions | 11.14.13h | | 1/1/2022 | 5/18/2022 | | 5/19/2022 | | | |
| Reissue Policies | Low-level Laser Therapy (LLLT) | 07.00.14g | | 9/30/2019 | 5/18/2022 | | 5/19/2022 | | | |
| Reissue Policies | Percutaneous Intradiscal Annuloplasty (IDET/PIRFT) | 11.14.14e | | 7/1/2013 | 5/18/2022 | | 5/19/2022 | | | |
| Reissue Policies | Full-Body Computerized Tomography (CT) Scan Screening | 09.00.24c | | 3/25/2015 | 5/18/2022 | | 5/19/2022 | | | |
| Reissue Policies | Non-Surgical Spinal Decompression Therapy | 07.08.01f | | 3/28/2016 | 5/18/2022 | | 5/19/2022 | | | |
| Coding Update | Modifier 50: Bilateral Procedure | 03.00.05s | | 4/1/2022 | | | 5/9/2022 | | | |
